FDA NDC Directory · JSON-LD · Markdown

AVSOLA

NDC 55513-670 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameinfliximab-axxq
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA761086
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsINFLIXIMAB (100 mg/10mL)
Marketing started20191212
Package count2

External sources

Source: openFDA. Public-domain (CC0).